Evaluation of64Cu(DO3A-xy-TPEP) as a potential PET radiotracer for monitoring tumor multidrug resistance

Bioconjugate Chemistry

Volumn 20, Issue 4, 2009, Pages 790-798

  Liu, Shuang ^a   Kim, Young Seung ^a   Zhai, Shizhen ^a   Shi, Jiyun ^a   Hou, Guihua ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(2 (DIPHENYLPHOSPHORYL) ETHYL)DIPHENYL[4 [[4,7,10 TRIS(CARBOXYMETHYL) 1,4,7,10 TETRAAZACYCLODODECAN 1 YL]METHYL]BENZYL]PHOSPHONIUM CU 64; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD; BRAIN; BREAST CANCER; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG UPTAKE; FEMALE; GLIOMA; HEART; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; INTESTINE; KIDNEY; LIVER; LUNG; MOUSE; MULTIDRUG RESISTANCE; MUSCLE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PROTEIN EXPRESSION; SPLEEN;

EID: 65249156461     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc800545e     Document Type: Article

References (72)

1. Ling, V. (1997) Multidrug resistance: molecular mechanisms and clinical relevance. Cancer Chemother. Pharmacol. 40, S3-S8.
2. Gros, P., Benneriah, Y. B., Croop, J. M., and Housman, D. E. (1986) Isolation and expression of a complementary DNA that confers multidrug resistance. Nature 323, 728-731.
3. Zaman, G. J. R., Flens, M. J., Vanleusden, M. R., Dehaas, M., Mulder, H. S., Lankelma, J., Pinedo, H. M., Scheper, R. J., Baas, F., Broxterman, H. J., and Borst, P. (1994) The human multidrug resistance-associated-protein MRP is a plasma-membrane drug-efflux pump. Proc. Natl. Acad. Sci. U.S.A. 91, 8822-8826.
4. Klein, I., Sarkadi, B., and Varadi, A. (1999) An inventory of the human ABC proteins. Biochim. Biophys. Acta 1461, 237-262.
5. Shapiro, A. B., and Ling, V. (1995) Reconstitution of drug transport by purified P-glycoprotein. J. Biol. Chem. 270, 16167-16175.
6. Mao, Q., Deeley, R. G., and Cole, S. P. (2000) Functional reconstitution of substrate transport by purified multidrug resistance protein MRP1 (ABCC1) in phospholipid vesicles. J. Biol. Chem. 275, 34166-34172.
7. Ferté, J. (2000) Analysis of the tangled relationships between P-glycoprotein-mediated multidrug resistance and the lipid phase of the cell membrane. Eur. J. Biochem. 267, 277-294.
8. Thomas, G. A., Barrand, M. A., Stewart, S., Rabbitts, P. H., Williams, E. D., and Tweentyman, P. R. (1994) Expression of the multidrug resistance-associated protein (MRP) gene in human lung tumors and normal tissue as determined by in situ hybridization. Eur. J. Cancer 30, 1705-1709.
9. Charpin, C., Vielh, P., Duffaud, F., Devictor, B., Andrac, L., Lavaut, M. N., Allasia, C., Horschowski, N., and Piana, L. (1994) Quantitative immunocytochemical assays of P-glycoprotein in breast carcinoma-correlation to messenger-RNA expression and to immunohistochemical prognostic indicators. J. Natl. Cancer Inst. 86, 1539-1545.
10. Hijazi, Y. M., Axiotis, C. A., Navarro, S., Steinberg, S. M., Horowitz, M. E., and Tsokos, M. (1994) Immunohistochemical detection of P-glycoprotein in Ewing's sarcoma and peripheral primitive neuroectodermal tumors before and after chemotherapy. Am. J. Clin. Pathol. 102, 61-67.
11. Chan, H., Grogan, T., Haddad, G., DeBoer, G., and Ling, V. (1997) P-glycoprotein expression: critical determinant in the response to osteosarcoma chemotherapy. J. Natl. Cancer Inst. 89, 1706-1715.
12. Lee, J. S., Scala, S., Matsumoto, Y., Dickstein, B., Robey, R., Zhan, Z., Altenberg, G., and Bates, S. E. (1997) Reduced drug accumulation and multidrug resistance in human breast cancer cells without associated P-glycoprotein or MRP overexpression. J. Cell Biol. 65, 513-526.
13. Linn, S. C., van Kalken, C. K., van Tellingen, O., van der Valk, P., van Groeningen, C. J., Kuiper, C. M., Pinedo, H. M., and Giaccone, G. (1994) Clinical and pharmacologic study of multidrug resistance reversal with vinblastine and bepridil. J. Clin. Oncol. 12, 812-819.
14. Lonn, U., Lonn, S., Nilsson, B., and Stenkvist, B. (1994) Intratumoral heterogeneity for amplified genes in human breast carcinoma. Int. J. Cancer 58, 40-45.
15. Sognier, M. A., Zhang, Y., Eberle, R. L., Sweet, K. M., Altenberg, G. A., and Belli, J. A. (1994) Sequestration of doxorubicin in vesciles in a multidrug-resistant cell line (LZ-100). Biochem. Pharmacol. 48, 391-101.
16. Chan, H., Lu, Y., Grogan, T., Haddad, G., Hipfner, D., Cole, S., Deeley, R., Ling, V., and Gallie, B. (1997) Multidrug resistance protein (MRP) expression in retinoblastoma correlates with the rare failure of chemotherapy despite cyclosporine for reversal of P-glycoprotein. Cancer Res. 57, 2325-2330.
17. Scheffer, G. L., Wijngaard, P. L., Flens, M. J., Izquierdo, M. A., Slovak, M. L., Pinedo, H. M., Meijor, C. J., Clevers, H. C., and Scheper, A. J. (1995) The drug resistance-related protein LRP is the human major vault protein. Nat. Med. 1, 578-582.
18. Litman, T., Brangi, M., Hudson, E., Fetsch, P., Abati, A., Ross, D. D., Miyake, K., Resau, J. H., and Bates, S. E. (2000) The multidrug-resistant phenotype associated with overexpression of the new ABC half-transporter, MXR (ABCG2). J. Cell Sci. 113, 2011-2021.
19. Wang, Y., Pan, X. Q., L'Heureux, F., and Georges, E. (1997) Overexpression of 40-kDa protein in human multidrug resistant cells. Biochem. Biophys. Res. Commun. 236, 483-488.
20. Wang, Y., Serfass, L., Roy, M. O., Wong, J., Bonneau, A. M., and Georges, E. (2004) Annexi-I expression modulate drug resistance in tumors cells. Biochem. Biophys. Res. Commun. 314, 565-570.
21. 99mTc-MIBI in the evaluation of breast cancer biology. Eur. J. Nucl. Med. Mol. Imaging 31, S88-S96.
22. Schomacker, K., and Schicha, H. (2000) Use of myocardial imaging agents for tumor diagnosis-a success story? Eur. J. Nucl. Med. 27, 1845-1863.
23. Sharma, V. (2004) Radiopharmaceuticals for assessment of multidrug resistance P-glycoprotein-mediated drug transport activity. Bioconjugate Chem. 15, 1464-1474.
24. Sharma, V., and Piwnica-Worms, D. (2005) Monitoring multidrug resistance P-glycoprotein drug transport activity with single-photon emission computed tomography and positron emission tomography radiopharmaceuticals. Top. Curr. Chem. 252 (Contrast Agents III), 155-178.
25. Vaidyanathan, G., and Zalutsky, M. R. (2004) Imaging drug resistance with radiolabeled molecules. Curr. Pharm. Des. 10, 2965-2979.
26. m-sestamibi imaging of inhibition of the multidrug resistance transporter in a mouse xenograft model of human breast cancer. Nucl. Med. Commun. 20, 115-122.
27. Filippi, L., Santoni, R., Manni, C., Danieli, R., Floris, R., and Schillaci, O. (2005) Imaging primary brain tumor by single-photon emission computed tomography (SPECT) with techne-tium-99m Sestamibi (MIBI) and Tetrofosmin. Curr. Med. Imaging Rev.1, 61-66.
28. Herman, L. W., Sharma, V., Kronauge, J. F., Barbarics, E., Herman, L. A., and Piwnica-Worms, D. (1995) Novel hexak-is(areneisonitrile)technetium(I) complexes as radioligands targeted to the multidrug resistance P-glycoprotein. J. Med. Chem. 38, 2955-2963.
29. 99mTc-sestamibi imaging of inhibition of the multidrug resistance transporter in a mouse xenograft model of human breast cancer. Nucl. Med. Commun. 20, 115-122.
30. 99mTc-Sestamibi accumulation in normal liver and drug resistant-tumors after the administration of the glycoprotein inhibitor, XR9576. Clin. Cancer Res. 9, 650-656.
31. 99mTc-labeled monocationic agents and a high-resolution stationary SPECT system. Nucl. Med. Biol. 31, 53-65.
32. 99mTc-labeled sestamibi and tetrofosmin. Nucl. Med. Biol. 32, 573-583.
33. Luker, G. D., Francisco, P. M., Dobkin, J., and Piwbica-Worms, D. (1997) Modulation of the multidrug resistance P-glycoprotein: Detection with technetium-99m sestamibi in vivo. J. Nucl. Med. 38, 369-372.
34. Márián, T., Szabo, G., Nagy, H., Szincsak, N., Juhasz, I., Galuska, L., Balkay, L., Mikecz, P., Tr<5n, L., and Krasznai, Z. (2003) In vivo and in vitro multitracer analysis of P-glycoprotein expression-related multidrug resistance. Eur. J. Nucl. Med. Mol. Imaging 30, 1147-1154.
35. Lorker, D. E., Krüger, M., Buchert, R., Bohuslavizki, K. H., Clausen, M., and Schumacker, U. (2001) In vitro and in vivo tracer characteristics of an established multidrug-resistant human colon cancer cell line. J. Nucl. Med. 42, 646-654.
36. 64Cu-Labeled triphenylphosphonium and triphenylarsonium cations as highly tumor-selective PET imaging agents. J. Med. Chem. 50, 5057-5069.
37. Kim, Y. S., Yang, C. T., Wang, J. J., Sreerama, S. G., Cao, Q., Li, Z., He, Z., Chen, X., and Liu, S. (2008) Radiolabeled triphenylphosphonium cations as highly tumor-selective imaging agents: Effects of radiometals, bifunctional chelators and molecular charge. J. Med. Chem. 51, 2971-2984.
38. Yang, C. T., Li, Y. X., and Liu, S. (2007) Synthesis and structural characterization of complexes of a DO3A-conjugated triphenylphosphonium cation with diagnostically important metal ions. Inorg. Chem. 46, 8988-8997.
39. 64Cu-labeled 2-(diphenylphosphoryl)ethyldiphenylphosphonium cations as highly selective tumor imaging agents: effects of linkers and chelates on biodistribution characteristics. Bioconjugate Chem. 19, 2008-2022.
40. Bahr, O., Wick, W., and Weller, M. (2001) Modulation of MDR/MRP by wild-type and mutant p53. J. Clin. Invest. 107, 643-645.
41. Bahr, O., Rieger, J., Duffner, F., Meyermann, R., Wller, M., and Wick, W. (2003) P-glycoprotein and multidrug resistance-associated protein mediate specific patterns of multidrug resistance in malignant glioma cell lines, but not in primary glioma cells. Brain Pathol. 13, 482-494.
42. Nakatsu, S., Kondo, S., Kondo, Y., Yin, D., Peterson, J. W., Kaakaji, R., Morinura, T., Kikuchi, H., and Takeuchi, J. (1977) Induction of apoptosis in multi-drug resistant (MDR) human glioblastoma cells by SN38, a metabolite of the camptothecin derivative CPT-11. Cancer Chemother. Pharmacol. 39, 417-423.
43. Le Jeune, N., Perek, N., Denoyer, D., and Dubois, F. (2004) Influence of gluthione depletion on plasma membrane cholesterol esterification and on Tc-99m-Sestamibi and Tc-99m-Tetrofosmin uptakes; a comparative study in sensitive U87MG and multidrug-resistant MRP1 human glioma cells. Cancer Biother. Radiopharm. 19, 411-121.
44. Ihnat, M. A., Lariviere, J. P., Warren, A. J., Ronde, N. L., Blaxall, J. R. N., Pierre, K. M., Turpie, B. W., and Hamilton, J. W. (1997) Suppression of P-glycoprotein expression and multidrug resistance by DNA cross-linking agents. Clin. Cancer Res. 3, 1339-1346.
45. Matsumoto, Y., Takano, H., Kunishio, K., Nagao, S., and Fojo, T. (2001) Expression of drug resistance genes in VP-16 and mAMSA-selected human carcinoma cells. Jpn. J. Cancer Res. 92, 778-784.
46. mdr-1. J. Natl. Cancer Inst. 89, 1524-1529.
47. Engel, J. B., Schally, A. V., Halmos, G., Baker, B., Nagy, A., and Keller, G. (2005) Targeted cytotoxic bombesin analog AN-215 effectively inhibits experimental human breast cancer with low induction of multi-drug resistance proteins. Endocrine-Related Cancer 12, 999-1009.
48. Savas, B., Kerr, P. E., and Pross, H. F. (2006) Lymphokine-activated killer cell susceptibility and adhesion molecule expression of multidrug resistant breast carcinoma. Cancer Cell Int., http:www.cancerci. com/content/6/1/24.
49. 68Ga radiopharmaceutical for SPECT and PET of MDR1 P-glycoprotein transport activity in vivo: validation in multidrug-resistant tumors and at the blood-brain barrier. J. Nucl. Med. 46, 354-364.
50. Ocheskey, J. A., Polyakov, V. R., Harpstrite, S. E., Oksman, A., Goldberg, D. E., Piwnica-Worms, D., and Sharma, V. (2003) Synthesis, characterization, and molecular structure of a gal-lium(III) complex of an amine-phenol ligand with activity against chloroquine-sensitive Plasmodium falciparum strains. J. Inorg. Biochem. 93, 265-270.
51. 99mTc-carbonyl complex as a functional probe of MDR1 P-glycoprotein transport activity. Mol. Imaging 1, 24-35.
52. Luker, G. D., Flagg, T. P., Sha, Q., Luker, K. E., Pica, C. M., Nichols, C. G., and Piwnica-Worms, D. (2001) MDR1 P-glycoprotein reduces influx of substrates without affecting membrane potential. J. Biol. Chem. 276, 49053-49060.
53. Slapak, C. A., Dahlheimer, J., and Piwnica-Worms, D. (2001) Reversal of multidrug resistance with LY335979. J. Clin. Pharmacol. 41, 29S-38S.
54. Rao, V. V., Herman, L. W., Kronauge, J. F., and Piwnica-Worms, D. (1998) A novel areneisonitrile Tc complex inhibits the transport activity of MDR P-glycoprotein. Nucl. Med. Biol. 25, 225-232.
55. Crankshaw, C. L., Marmion, M., Luker, G. D., Rao, V., Dahlheimer, J., Burleigh, B. D., Webb, E., Deutsch, K. F., and Piwnica-Worms, D. (1998) Novel technetium (III)-Q complexes for functional imaging of multidrug resistance (MDR1) P-glycoprotein. J. Nucl. Med. 39, 77-86.
56. Luker, G. D., Rao, V. V., Crankshaw, C. L., Dahlheimer, J., and Piwnica-Worms, D. (1997) Characterization of phosphine complexes of technetium(III) as transport substrates of the multidrug resistance P-glycoprotein and functional markers of P-glycoprotein at the blood-brain barrier. Biochemistry 36, 14218-14227.
57. Pichler, A., Prior, J. L., and Piwnica-Worms, D. (2004) Imaging reversal of multidrug resistance in living mice with bioluminescence: MDR1 P-glycoprotein transports coelentera-zine. Proc. Natl. Acad. Sci. U.S.A. 101, 1702-1707.
58. Gatmaitan, Z. C., and Arias, I. M. (1993) Structure and function of P-glycoprotein in normal liver and small intestine. Adv. Pharmacol. 24, 77-97.
59. Lee, C. H., Bradley, G., Zhang, J. T., and Ling, V. (1993) Differential expression of P-glycoprotein genes in primary rat hepatocytes culture. J. Cell Physiol. 157, 392-402.
60. Mayer, R., Kartenbeck, J., Buchler, M., Jedlitschky, G., Leier, I., and Keppler, D. (1995) Expression of the MRP gene-encoded conjugate export pump in liver and its selective absence from the canalicular membrane in transport deficient mutant hepato-cytes. J. Cell Biol. 131, 137-150.
61. Carvalho, P. A., Chiu, M. L., Kronauge, J. F., Kawamura, M., Jones, A. G., Holman, B. L., and Piwnica-Worms, D. (1992) Subcellular distribution and analysis of technetium-99m-MIBI in isolated perfused rat hearts. J. Nucl. Med. 33, 1516-1521.
62. +. J. Nucl. Med. 49, 1336-1344.
63. 99mTcN-MPO: a new heart imaging agent. J. Nucl. Cardiol. Submitted.
64. Ochoa, S. (1955) Malic dehydrogenase from pig heart. Methods Enzymol. 1, 735-739.
65. Platts, E. A., North, T. L., Pickett, R. D., and Kelly, J. D. (1995) Mechanism of uptake of technetium-tetrofosmin I: uptake into isolated adult rat ventricular myocytes and subcellular localization. J. Nucl. Cardiol. 2, 317-326.
66. Younes, A., Songadele, J. A., Maublant, J., Platts, E., Pickett, R., and Veyre, A. (1995) Mechanism of uptake of technetium-tetrofosmin II: uptake into isolated adult rat heart mitochondria. J. Nucl. Cardiol. 2, 327-333.
67. Qadir, M., O'Loughlin, K. L., Fricke, S. M., Williamson, N. A., Greco, W. R., Minderman, H., and Baer, M. (2005) Cyclosporin A is a broad-spectrum multidrug resistance modulator. Clin. Cancer Res. 11, 2320-2326.
68. Kroemer, G., Dallaporta, B., and Resche-Rigon, M. (1998) The mitochondrial death/life regulator in apoptosis and necrosis. Annu. Rev. Physiol. 60, 619-642.
69. Modica-Napolitano, J. S., and Aprille, J. R. (2001) Delocalized lipophilic cations selectively target the mitochondria of carcinoma cells. Adv. Drug Delivery Rev.49, 63-70.
70. Duchen, M. R. (2004) Mitochondria in health and disease: perspectives on a new mitochondrial biology. Mol. Aspects Med. 25, 365-451.
71. Gottlieb, E., and Thompson, C. B. (2002) Targeting the mitochondria to enhance tumor suppression. Methods Mol. Biol. 223, 543-554.
72. Mannella, C. A. (2006) The relevance of mitochondrial membrane topology to mitochondrial function. Biochem. Biophys. Acta 1762, 140-147. BC800545E